Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. embryon

EMBRYON

EMBRYON - Develop and commercialize a highly innovative diagnostic-imaging product, improving success rates in the Assisted Reproduction IVF sector

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 EMBRYON project word cloud

Explore the words cloud of the EMBRYON project. It provides you a very rough idea of what is the project "EMBRYON" about.

extension    billion    leader    optimization    generation    2020    acs    patented    imaging    gross    easier    utero    births    1400    six    cycles    units    20    clinics    predictors    big    100    switzerland    social    introduces    image    fertilization    approximate    nearly    ll    infertility    rate    innovations    automated    cycle    therapy    couples    shape    smarter    ivf    ph1    lifetime    images    software    fda    solutions    precision    embryon    sales    forecasts    invasive    costly    simpler    ph2    specialists    proprietary    publish    procedure    instruments    ww    scan    despite    certify    ongoing    favoring    1200    deep    italy    lab    stressful    reactivity    cheaper    microscope    observations    finalize    org    partnership    merges    heavy    dollars    prototype    ce    outcomes    embryo    ethical    15    rates    million    45    embryos    clearance    patterns    market    morphological    double    identification    patents    reproductive    commercial    clinical    compliant    diagnostic    vitro    nikon    handcrafted    plan    revenues    innovation    validation    transferred    newco    physician    validated    improves    algorithms    favored    pregnancy    2013    microscopy    patients    issue    scientists    10    subjective    overcoming    global    deeper    leaving    regulation    amongst    safer    trials    last   

Project "EMBRYON" data sheet

The following table provides information about the project.

Coordinator		 ADVANCED COMPUTER SYSTEMS A.C.S. SPA 

Organization address
address: VIA DELLA BUFALOTTA 378
city: ROMA
postcode: 139
website: www.acsys.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Project website http://www.unbimbo.it/en/index.html
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ADVANCED COMPUTER SYSTEMS A.C.S. SPA IT (ROMA) coordinator 50˙000.00

Map

 Project objective

Infertility is a heavy social issue,experienced by nearly one in six couples during reproductive lifetime. In Vitro Fertilization (IVF) is growing 8-10% p.a.,to 1.5 million therapy cycles and 7.5 billion dollars in 2013. Despite stressful and costly procedures,IVF success rate is low (15-20% births/cycle),leaving big opportunities for innovation and process optimization. EMBRYON introduces to IVF clinics and specialists a last-generation diagnostic-imaging system,favoring better outcomes through deeper,smarter analysis of clinical images. It merges tailored image-processing software and algorithms,patented by ACS,with a high-end commercial IVF microscope.A prototype is under validation with top clinics in Italy and Switzerland,supported by Nikon Instruments (global leader in IVF microscopy). EMBRYON improves the key success factor of any IVF procedure:the identification of 1-2 embryos with best “pregnancy potential” to be transferred in utero,amongst 5-10 generated in vitro. EMBRYON’s precision is double than current handcrafted approaches,favoring higher success rates. It is safer (100% not invasive),thus simpler to certify and adopt,fully compliant with ethical regulation,easier to use (no change to lab procedures) and cheaper than similar products. Key innovations 1. Automated deep scan of embryo shape,overcoming today’s subjective and approximate observations carried by the physician 2. Proprietary algorithms for the measurement of complex morphological patterns,strong predictors of potential Sales forecasts are 1200-1400 units (40-45 M€ gross revenues) by 2020 in Europe and US,favored by: - High reactivity of the IVF sector (scientists/patients) to validated solutions improving outcomes - Commercial partnership with a global IVF microscopy leader In Ph1 we’ll finalize and publish the ongoing clinical studies and make a deep market analysis for Europe-US In Ph2 we plan CE/FDA clearance,WW extension of patents,3 trials in Europe-US,set-up of newco and sales org

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMBRYON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMBRYON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

HEADSpAcE (2019)

Translational studies of HEAD and neck cancer in South America and Europe

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More